ask="6.10"
ask_size="300"
average_daily_volume="177210"
bid="4.45"
bid_size="700"
book_value="1.02"
change="+0.20"
change_from_200_day_moving_average="-0.81"
change_from_50_day_moving_average="-0.09"
change_from_52_week_high="-5.96"
change_From_52_week_low="0.40"
change_in_percent="+4.76%"
close="4.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.76"
ebitda="-21.91M"
eps_estimate_current_year="-0.78"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.76"
ex_dividend_date="N/A"
float_shares="30151000"
high="4.45"
high_52_weeks="10.36"
last_trade_date="3/1/2017"
last_trade_price="4.40"
last_trade_size="9563"
last_trade_time="4:00pm"
low="4.20"
low_52_weeks="4.00"
market_capitalization="140.95M"
moving_average_200_day="5.21"
moving_average_50_day="4.49"
name="INVIVO THERAPEUTICS"
notes="N/A"
one_year_target_price="19.42"
open="4.30"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-15.53%"
percent_change_from_50_day_moving_average="-2.08%"
percent_change_from_52_week_high="-57.53%"
percent_change_from_52_week_low="+10.00%"
previous_close="4.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.10"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="32033000"
short_ratio="14.82"
stock_exchange="NGM"
symbol="NVIV"
volume="230300"
weeks_range_52="4.00 - 10.36"
